8208589 Monitoring new European chemical legislation on diisocyanates with epidemiological research: cohort and cluster-randomized trial

<h3>Objective</h3> Diisocyanates (DI) are crucial in producing polyurethane-based materials but can cause respiratory diseases like work-related DI asthma, affecting a four-digit range in the EU annually. In 2016, Germany proposed a new approach within the EU-wide regulation on chemicals (REACH), including mandatory training for employees on the safe handling of DI. The EU implemented this regulation in 2023 to enhance worker health and safety. To scientifically monitor and evaluate this new regulation an epidemiological study was planned. <h3>Material and Methods</h3> At first, a feasibility study was launched in 2018 as part of a large cooperative project involving various organisations. The aim was to recruit enough companies with approximately 1,500 DI-exposed employees (+ 200 non-exposed controls) but also to design the main study. Participating organizations, including accident insurance institutions and manufacturer associations, promoted involvement among companies. Interested companies were visited and further informed by conference calls, whereas the employees were informed through the company’s occupational health practitioner. <h3>Results</h3> Within the feasibility study 35 companies with &gt;1,300 DI-exposed employees agreed to participate. A 5-year prospective cohort study will assess exposure to DI and related health effects while an embedded cluster-randomized trial with wait-listed control groups will test the effectiveness of the training measures in terms of exposure reduction. In 2022, 29 companies remained, of which 26 were randomised for the intervention. The field phase began in 2023 with 28 company sites visited since then, including 15 in the intervention part. <h3>Conclusion</h3> The preparatory phase, supported by institutional collaboration, successfully established a nationwide sample of isocyanate-using companies for a 5-year cohort study. The combination of interventional and observational study designs can answer research questions and exemplify for an evidence-based regulation in European chemical safety.

Authors

Institutions

Publication Details

Published
2025-10-01
DOI
https://doi.org/10.1136/oemed-2025-epicohabstracts.285
Primary Topic
Human Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

8208589 Monitoring new European chemical legislation on diisocyanates with epidemiological research: cohort and cluster-randomized trial

Chloé Charlotte Schröder, Claudia Drossard, Uwe Rose, Heiko Udo Käfferlein et al.
Human Health and Disease
article

8208589 Monitoring new European chemical legislation on diisocyanates with epidemiological research: cohort and cluster-randomized trial

Chloé Charlotte Schröder, Claudia Drossard, Uwe Rose, Heiko Udo Käfferlein, Michael Giersig, P. Kujath, John E. Nestler, Nikita Reichelt, Stefanie K Kösling
article en

Abstract

<h3>Objective</h3> Diisocyanates (DI) are crucial in producing polyurethane-based materials but can cause respiratory diseases like work-related DI asthma, affecting a four-digit range in the EU annually. In 2016, Germany proposed a new approach within the EU-wide regulation on chemicals (REACH), including mandatory training for employees on the safe handling of DI. The EU implemented this regulation in 2023 to enhance worker health and safety. To scientifically monitor and evaluate this new regulation an epidemiological study was planned. <h3>Material and Methods</h3> At first, a feasibility study was launched in 2018 as part of a large cooperative project involving various organisations. The aim was to recruit enough companies with approximately 1,500 DI-exposed employees (+ 200 non-exposed controls) but also to design the main study. Participating organizations, including accident insurance institutions and manufacturer associations, promoted involvement among companies. Interested companies were visited and further informed by conference calls, whereas the employees were informed through the company’s occupational health practitioner. <h3>Results</h3> Within the feasibility study 35 companies with &gt;1,300 DI-exposed employees agreed to participate. A 5-year prospective cohort study will assess exposure to DI and related health effects while an embedded cluster-randomized trial with wait-listed control groups will test the effectiveness of the training measures in terms of exposure reduction. In 2022, 29 companies remained, of which 26 were randomised for the intervention. The field phase began in 2023 with 28 company sites visited since then, including 15 in the intervention part. <h3>Conclusion</h3> The preparatory phase, supported by institutional collaboration, successfully established a nationwide sample of isocyanate-using companies for a 5-year cohort study. The combination of interventional and observational study designs can answer research questions and exemplify for an evidence-based regulation in European chemical safety.

Institute for Prevention and Occupational Medicine (DE), Federal Institute for Occupational Safety and Health (DE)
Openalex Percentile: Top 60%
Human Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.